Uptake of Trastuzumab Biosimilars for the Treatment of HER2-Positive Breast Cancer: A Real-World Experience from a Cancer Center

• मुख्य लेखकों: Michela Piezzo (लेखक), Roberta D'Aniello (लेखक), Ilaria Avallone (लेखक), Bruno Barba (लेखक), Daniela Cianniello (लेखक), Stefania Cocco (लेखक), Antonio D'Avino (लेखक), Germira Di Gioia (लेखक), Vincenzo Di Lauro (लेखक), Giuseppina Fusco (लेखक), Raffaele Piscitelli (लेखक), Claudia von Arx (लेखक), Michelino De Laurentiis (लेखक), Piera Maiolino (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: MDPI AG, 2021-05-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Background: The introduction of trastuzumab biosimilars in clinical practice plays an important role in promoting the sustainability of healthcare systems. By contrast, the switching process can be challenging to the clinics. This survey describes the switching process at a National Cancer Institute...